Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose

Clinical trial NCT01543087 · COMPLETED

Trial details

NCT number: NCT01543087
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Meningococcal Infection

Start date: 2012-09-07
Primary completion: 2018-01-05
Enrollment: 698

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.